4 Results for "

MAX40279

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "MAX40279" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-145723
CAS No.: 2070931-57-4
Purity:  97.04%
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 can be used for the research of acute myelogenous leukemia (AML) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145723C
CAS No.: 2388506-44-1
Purity:  99.26%
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 hemiadipate is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemiadipate is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 hemiadipate inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 hemiadipate can be used for the research of acute myelogenous leukemia (AML) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145723B
CAS No.: 2388506-43-0
Purity:  99.56%
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 hemifumarate is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 hemifumarate inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 hemifumarate can be used for the research of acute myelogenous leukemia (AML) .
loading...
    loading...
Cat. No.: HY-145723A
CAS No.: 2388506-51-0
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 hydrochloride is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hydrochloride is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 hydrochloride inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 hydrochloride can be used for the research of acute myelogenous leukemia (AML) .
loading...
    loading...